glucothera 1,4 m/v glucoza
haemopharm biofluids s.r.l. - italia - combinatii - sol. dial. perit. - preparate pentru dializa peritoneala produse hipertone
glucothera 2,4 m/v glucoza
haemopharm biofluids s.r.l. - italia - combinatii - sol. dial. perit. - preparate pentru dializa peritoneala produse hipertone
glucothera 4 m/v glucoza
haemopharm biofluids s.r.l. - italia - combinatii - sol. dial. perit. - preparate pentru dializa peritoneala produse hipertone
glucothera 1,4 m/v glucoza
haemopharm biofluids s.r.l. - italia - combinatii - sol. dial. perit. - preparate pentru dializa peritoneala produse hipertone
glucothera 2,4 m/v glucoza
haemopharm biofluids s.r.l. - italia - combinatii - sol. dial. perit. - preparate pentru dializa peritoneala produse hipertone
glucothera 4 m/v glucoza
haemopharm biofluids s.r.l. - italia - combinatii - sol. dial. perit. - preparate pentru dializa peritoneala produse hipertone
irnother concentrat pentru solutie perfuzabila 100 mg/5 ml
therdose pharma pvt. ltd. - irinotecanum - concentrat pentru solutie perfuzabila - 100 mg/5 ml
celvapan
nanotherapeutics bohumil, s.r.o. - whole virion influenza vaccine, inactivated containing antigen of strain a/california/07/2009 (h1n1)v - disease outbreaks; influenza, human; immunization - vaccinuri - profilaxia gripei cauzate de virusul a (h1n1) v 2009. celvapan ar trebui să fie utilizate în conformitate cu recomandările oficiale.
lumeblue (previously known as methylthioninium chloride cosmo)
alfasigma s.p.a. - metiltioniniu - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.
revolade
novartis europharm limited - eltrombopag - purpură, trombocitopenică, idiopatică - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 și 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 și 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.